广东省新型冠状病毒肺炎疫情防控期间脑血管病诊断和治疗工作指引(2022年版)

Guideline for diagnosis and treatment of cerebrovascular diseases during the coronavirus disease 2019 epidemic period in Guangdong Province(2022)

新型冠状病毒肺炎(coronavirus disease 2019,COVID-⑼,具有高度传染性和严重致病性,至今依然肆虐全球,在我国也起伏反复。卒中是我国致死致残的最主要疾病,其急诊救治时间窗短暂,且康复治疗和二级预防必须长期坚持。如何做好疫情防控新形势下的脑血管病诊治工作,已成当前神经科医生面临的严峻挑战。在广东省医学会和广东省医疗质量控制中心指导下,广东省医学会脑血管病学分会和广东省神经系统疾病(脑血管病)质控中心专家组,参考国内同行经验和相关政策文献,更新了本工作指引,包括关注脑血管病合并COVID-19的风险、急诊绿色通道管理、溶栓和血管内介入治疗管理、外科手术治疗管理、病房和门诊工作管理、护理管理以及重视疫苗接种后发生的脑血管病等多个方面,供同行在临床工作中参照执行。

The coronavirus disease 2019(COVID-19)is highly contagious and severely pathogenic and still spreading in the world and also in China.Stroke is the most important disease causing death and disability in our country,the time window of its emergency treatment is short,and the rehabilitation and secondary prevention must be adhered to for a long time.How to manage the cerebrovascular diseases properly and at the same time strictly prevent and control the epidemic represents a serious new challenge for neurologists.Under the guidance of Guangdong Medical Association and Guangdong Medical Quality Control Center,the experts of the Cerebrovascular Branch of Guangdong Medical Association and the Quality Control Center of Nervous System Disease(Cerebrovascular Diseases)of Guangdong Province revised this working guideline after a thorough review of available evidence including experience of domestic peers and relevant policy literature of the government and an extensive discussion among experts.The working guideline includes the risk of cerebrovascular diseases combined with COVID-19,the management for emergency medical service,thrombolysis and endovascular therapy,surgical treatment,ward and outpatient work,nursing service and cerebrovascular diseases after COVID-19 vaccination,etc.The working guideline is helpful to assist medical staffs in the clinical practice during the coronavirus disease outbreak.